Get the Stockscreener App
1.44
2.04%
-0.03
Biote Corp stock is traded at $1.44, with a volume of 277.21K.
It is down -2.04% in the last 24 hours and down -32.08% over the past month.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
See More
Previous Close:
$1.47
Open:
$1.46
24h Volume:
277.21K
Relative Volume:
1.40
Market Cap:
$44.23M
Revenue:
$192.22M
Net Income/Loss:
$31.60M
P/E Ratio:
1.90
EPS:
0.7579
Net Cash Flow:
$28.33M
1W Performance:
+5.88%
1M Performance:
-32.08%
6M Performance:
-51.52%
1Y Performance:
-62.20%
1-Day Range:
$1.40
$1.48
1-Week Range:
$1.355
$1.685
52-Week Range:
$1.35
$4.7498
Biote Corp Stock (BTMD) Company Profile
Name
Biote Corp
Sector
Industry
Phone
972-486-9346
Address
1875 W. WALNUT HILL LN #100, IRVING
Compare BTMD vs PSNYW, SHMD, GOODO, DWLD, QQQE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BTMD
Biote Corp. Class A Common Stock
|
5.89 | 33.33M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
5.30 | 493.05M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
7.42 | 364.76M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
19.92 | 372.90M | 0 | 0 | 0 | 0.00 |
DWLD
Davis Select Worldwide ETF
|
43.93 | 0 | 0 | 0 | 0 | 0.00 |
QQQE
Direxion NASDAQ-100 Equal Weigh
|
99.50 | 0 | 0 | 0 | 0 | 0.00 |
Biote Corp Stock (BTMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-25 | Downgrade | B. Riley Securities | Buy → Neutral |
| Dec-16-24 | Initiated | Craig Hallum | Buy |
| Feb-20-24 | Initiated | B. Riley Securities | Buy |
| Feb-01-24 | Initiated | Jefferies | Buy |
| Jun-24-22 | Initiated | Cowen | Outperform |
| Jun-23-22 | Initiated | ROTH Capital | Buy |
View All
Biote Corp Stock (BTMD) Latest News
Macro Review: Does biote Corp align with a passive investing strategyMarket Activity Recap & Capital Efficient Trading Techniques - baoquankhu1.vn
biote Corp. Stock Plummets to New 52-Week Low of $1.68 - Markets Mojo
biote Corp. Hits 52-Week Low of $1.73 Amid 72.2% Decline - Markets Mojo
biote Corp. Hits New 52-Week Low at $1.86 Amidst Major Decline - Markets Mojo
Whale Trades: What hedge funds are buying biote CorpWeekly Trend Report & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Setup Watch: Is biote Corp gaining market share2026 Trends & AI Driven Stock Reports - baoquankhu1.vn
Does biote Corp have declining or rising EPS2026 Momentum Check & Community Trade Idea Sharing Platform - baoquankhu1.vn
Can biote Corp stock outperform in a bear market2026 Fundamental Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Inventory Forecasting Woes: Biote Corp. Faces Material Risk From Demand Volatility and Stock Management Challenges - TipRanks
Biote 2025 Annual Report: Hormone Optimization Practice Growth, Risk Factors, and Business Overview - Minichart
Biote Corp. Q4 2025 Earnings Call Insights - Intellectia AI
Cowen Maintains Buy on biote Corp. (BTMD) March 2026, PT $2.50 - Meyka
Biote Corp. Earnings Call Maps Pain Now, Promise Later - The Globe and Mail
Biote : Fourth Quarter 2025 Earnings Call Transcript - marketscreener.com
Roth/MKM cuts Biote stock price target on procedure uncertainty By Investing.com - Investing.com India
B. Riley Financial Cuts biote (NASDAQ:BTMD) Price Target to $2.00 - MarketBeat
TD Cowen cuts Biote stock price target on guidance miss By Investing.com - Investing.com Canada
TD Cowen cuts Biote stock price target on guidance miss - Investing.com
Roth/MKM cuts Biote stock price target on procedure uncertainty - Investing.com
Biote Corp (BTMD) Q4 EPS Plunges 84% to $0.06 Despite Flat Revenue at $49.5M - AlphaStreet
biote Corp earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia
biote Corp. (NASDAQ:BTMD) Q4 2025 Earnings Call Transcript - Insider Monkey
B. Riley Adjusts Price Target on biote to $2 From $3, Maintains Neutral Rating - marketscreener.com
Biote Corp (BTMD) Q4 2025 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges By GuruFocus - Investing.com Canada
biote Corp. Q4 2025 Earnings Call Summary - Yahoo Finance
biote Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Biote Corp misses Q4 2025 earnings expectations By Investing.com - Investing.com India
Earnings call transcript: Biote Corp misses Q4 2025 earnings expectations - Investing.com
BTMD: Q4 revenue fell on clinic attrition and recall, but sales and tech investments target H2 2026 growth - TradingView
biote Corp. (BTMD) Q4 Results Surpass Expectations for Earnings and Revenue - Bitget
Biote Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Biote Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
biote (BTMD) Q4 2025 Earnings Call Transcript - The Motley Fool
biote Corp. (BTMD) Q4 Earnings and Revenues Top Estimates - Yahoo Finance
Biote Q4 Earnings, Revenue Fall; Shares Drop After Hours - marketscreener.com
biote (NASDAQ:BTMD) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Biote Corp. (BTMD) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
BTMD: 2025 saw lower revenue and margins, but growth is expected to resume in H2 2026 - TradingView
Biote (NASDAQ: BTMD) posts 2025 results and guides to lower 2026 Adjusted EBITDA - Stock Titan
Biote Reports Fourth Quarter and Full Year 2025 Financial Results - marketscreener.com
Hormone therapy firm Biote to boost sales as 2026 procedure revenue declines - Stock Titan
Earnings Outlook For Biote - Benzinga
Biote Corp expected to post earnings of 5 cents a shareEarnings Preview - TradingView
Mayo Clinic posts record profit of $1.5B in 2025 - AOL.com
Breakout Move: Is biote Corp forming higher highs and higher lows2025 Year in Review & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Bank Watch: Does biote Corp have declining or rising EPS2025 Risk Factors & Long Hold Capital Preservation Plans - baoquankhu1.vn
BTMDRevenue by Segment - Quiver Quantitative
Biote Corp Stock (BTMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
3.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):